AVAILABLE MEDICINE FOR Sunitinib
There are no products to list.
Introduction to Sunitinib
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor used for cancer treatment. Sunitinib was approved by the U.S. Food and Drug Administration (FDA) on January 26, 2006, for the treatment of gastrointestinal stromal tumor (GIST) after disease progression or intolerance to other medication.
